Case Reports in Medicine (Jan 2019)

Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature

  • Mohammed Al-Sadawi,
  • Romy Rodriguez Ortega,
  • Natalie Sun,
  • Madina Abdurahimova,
  • Samy I. McFarlane

DOI
https://doi.org/10.1155/2019/8936478
Journal volume & issue
Vol. 2019

Abstract

Read online

Neurotoxicity manifested as confusion and seizures has been recognized as a side effect of multiple cephalosporins including ceftazidime. Renal impairment and inappropriate dosing are the most common contributors to the development of neurological abnormalities in patients receiving these antibiotics. The presence of baseline neurological abnormalities likely contributes to the frequency of these adverse events. Here, we present a case of a 78-year-old man that developed altered mental status and myoclonic movement after initiation of ceftazidime in the setting of mild renal dysfunction. Resolution of clinical picture was evident after 48 hours of discontinuation of the antibiotic without additional interventions.